JORDAN WALKER: Open Payments
NPI 1750939831 · UMATILLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$853 in 38 payments from 13 companies in 2025. Trend: 2023 $776 · 2024 $773 · 2025 $853
Food & beverage: $853
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $175 |
| AstraZeneca Pharmaceuticals LP | 6 | $135 |
| Lilly USA, LLC | 4 | $93 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Novo Nordisk Inc | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $61 |
| Exact Sciences Corporation | 2 | $49 |
| PFIZER INC. | 2 | $42 |
| Vifor Pharma, Inc. | 1 | $28 |
Products named: VRAYLAR, TRELEGY ELLIPTA, AIRSUPRA, CAPLYTA, Kerendia, JARDIANCE, UBRELVY, BREZTRI.
Industry payments across FL — which companies pay providers there.
